Jonathan Emmanuel Perales Martínez

Mr. Jonathan Emmanuel Perales Martínez


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CMCarlos Roberto Montes-de-Oca-Saucedo
Carlos Roberto Montes-de-Oca-Saucedo
JMJonathan Emmanuel Perales Martínez
Jonathan Emmanuel Perales Martínez
JAJuan C. Arellano-Barrientos
Juan C. Arellano-Barrientos
LRLuis Edgar Rodríguez-Tovar
Luis Edgar Rodríguez-Tovar
ANAlicia M. Nevárez-Garza
Alicia M. Nevárez-Garza
UZIEL CASTILLO VELAZQUEZUZIEL CASTILLO VELAZQUEZ
UZIEL CASTILLO VELAZQUEZ
Cannabidiol (CBD), a phytocannabinoid derived from Cannabis sativa, has demonstrated therapeutic potential across various diseases, including cancer. This study evaluates the cytotoxic effects of CBD on three human cancer cell lines (HeLa, MDA-MB-231, and CaCo-2) and two non-cancerous cell lines (HaCaT and HUVEC) used as a control. Cells were treated with CBD at concentrations of 5, 10, and 20 µM for 24, 48, 72, and 96 h. Cytotoxicity was assessed using MTT assays, nuclear morphology was evaluated via DAPI staining, and cell death mechanisms were analyzed through flow cytometry with apoptosis/necrosis markers. The LC50 values at 24 h were determined as follows: HeLa (9.4 µM), MDA-MB-231 (10.3 µM), and CaCo-2 (4.3 µM). CBD treatment induced morphological changes characteristic of cell stress and death in cancer cells, observed by optical microscopy after 24, 48, 72, and 96 h of exposure. These findings highlight the potential of CBD as an adjunctive therapeutic agent for cancer treatment versus non-malignant cells.

8 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CMCarlos Roberto Montes-de-Oca-Saucedo
Carlos Roberto Montes-de-Oca-Saucedo
JMJonathan Emmanuel Perales Martínez
Jonathan Emmanuel Perales Martínez
GMGloria Arely Guillén Meléndez
Gloria Arely Guillén Meléndez
LRLuis Edgar Rodríguez-Tovar
Luis Edgar Rodríguez-Tovar
ANAlicia M. Nevárez-Garza
Alicia M. Nevárez-Garza
UZIEL CASTILLO VELAZQUEZUZIEL CASTILLO VELAZQUEZ
UZIEL CASTILLO VELAZQUEZ
Cannabidiol (CBD), a phytocannabinoid derived from Cannabis sativa, has demonstrated therapeutic potential across various diseases, including cancer. This study evaluates the cytotoxic effects of CBD on three human cancer cell lines (HeLa, MDA-MB-231, and CaCo-2) and two non-cancerous cell lines (HaCaT and HUVEC) used as a control. Cells were treated with CBD at concentrations of 5, 10, and 20 µM for 24, 48, 72, and 96 h. Cytotoxicity was assessed using MTT assays, nuclear morphology was evaluated via DAPI staining, and cell death mechanisms were analyzed through flow cytometry with apoptosis/necrosis markers. The LC50 values at 24 h were determined as follows: HeLa (9.4 µM), MDA-MB-231 (10.3 µM), and CaCo-2 (4.3 µM). CBD treatment induced morphological changes characteristic of cell stress and death in cancer cells, observed by optical microscopy after 24, 48, 72, and 96 h of exposure. These findings highlight the potential of CBD as an adjunctive therapeutic agent for cancer treatment versus non-malignant cells.